← Back to Discover
Jones Hill Capital LP
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $589,169,587
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- BIOMARIN PHARMACEUTICAL INC · COM · 09061G101 · shares: $70,311,540
- BIOCRYST PHARMACEUTICALS INC · COM · 09058V103 · shares: $59,003,889
- TRAVERE THERAPEUTICS INC · COM · 89422G107 · shares: $56,503,250
- INDIVIOR PHARMACEUTICALS INC · COM · 45579U109 · shares: $54,731,657
- PHARVARIS N V · COM · N69605108 · shares: $31,327,846
- CELCUITY INC · COM · 15102K100 · shares: $30,448,288
- IONIS PHARMACEUTICALS INC · COM · 462222100 · shares: $26,782,231
- SUPERNUS PHARMACEUTICALS · COM · 868459108 · shares: $25,896,522
- NUVATION BIO INC · COM CL A · 67080N101 · shares: $25,127,122
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $21,060,119
Reported holdings
33 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 1,171,859 shares | $70,311,540 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 7,083,300 shares | $59,003,889 |
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | — | 959,634 shares | $56,503,250 |
| INDIVIOR PHARMACEUTICALS INC | COM | 45579U109 | — | 1,526,685 shares | $54,731,657 |
| PHARVARIS N V | COM | N69605108 | — | 987,637 shares | $31,327,846 |
| CELCUITY INC | COM | 15102K100 | — | 382,901 shares | $30,448,288 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 599,826 shares | $26,782,231 |
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | — | 601,685 shares | $25,896,522 |
| NUVATION BIO INC | COM CL A | 67080N101 | — | 4,486,986 shares | $25,127,122 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 652,218 shares | $21,060,119 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 1,447,156 shares | $20,723,274 |
| BICARA THERAPEUTICS INC | COM | 055477103 | — | 1,064,233 shares | $19,805,376 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 5,237,628 shares | $19,745,858 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 142,558 shares | $14,116,093 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 2,504,651 shares | $13,174,464 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 106,528 shares | $12,159,106 |
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | — | 83,426 shares | $11,833,144 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 384,278 shares | $11,639,781 |
| ERASCA INC | COM | 29479A108 | — | 610,118 shares | $8,944,330 |
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | — | 892,532 shares | $8,452,278 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 80,017 shares | $7,045,497 |
| NEUROGENE INC | COM | 64135M105 | — | 217,700 shares | $6,056,414 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 886,428 shares | $6,045,439 |
| TONIX PHARMACEUTICALS HLDG C | COM NEW | 890260839 | — | 563,739 shares | $5,490,818 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 502,587 shares | $4,965,560 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 300,900 shares | $4,847,499 |
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 126,744 shares | $3,610,937 |
| ATTOVIA THERAPEUTICS INC | COM | 04987L102 | — | 182,295 shares | $3,124,536 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 276,830 shares | $2,020,859 |
| LEXEO THERAPEUTICS INC | COM | 52886X107 | — | 593,737 shares | $2,006,831 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 206,397 shares | $1,783,270 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 122,169 shares | $230,899 |
| ALVOTECH | ORDINARY SHARES | L01800108 | — | 26,700 shares | $154,860 |